Commentary: safety of anti-TNF use in pregnancy

被引：0
|
作者：
Hart, Ailsa [1 ]
机构：
[1] St Marks Hosp, IBD Unit, Harrow, Middx, England
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2020年 / 51卷 / 01期
关键词：
INFLAMMATORY-BOWEL-DISEASE; INFLIXIMAB; CONSENSUS;
D O I：
10.1111/apt.15548
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THIS IS A SPECIAL COMMENTARY ON "INTENTIONAL INFLIXIMAB USE DURING PREGNANCY FOR INDUCTION OR MAINTENANCE OF REMISSION IN CROHN'S DISEASE" BY MAHADEVAN, U., KANE, S., SANDBORN, W.J., COHEN, R.D., HANSON, K., TERDIMAN, J.P., AND BINION, D.G., ORIGINALLY PUBLISHED IN AP&T IN 2005. DOI:
引用
收藏
页码：205 / 206
页数：2
相关论文
共 50 条
  • [1] Safety of anti-TNF agents in pregnancy
    De Felice, Kara M.
    Kane, Sunanda
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (03) : 661 - 667
  • [2] Safety of Immunomodulators and Anti-TNF Therapy in Pregnancy
    Khadija H. Chaudrey
    Sunanda V. Kane
    [J]. Current Treatment Options in Gastroenterology, 2015, 13 (1) : 77 - 89
  • [3] Editorial: thiopurine/anti-TNF use during pregnancy-more encouraging safety data
    Chowdhury, Reezwana
    Kane, Sunanda
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1409 - 1410
  • [4] The use of anti-TNF alpha medications for rheumatologic disease in pregnancy
    Clowse, Megan E. B.
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2010, 2 : 199 - 209
  • [5] Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy
    Khan, Nabeel
    Asim, Hamna
    Lichtenstein, Gary R.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2014, 13 (12) : 1699 - 1708
  • [6] Optimal anti-TNF stop week during pregnancy depends on anti-TNF type
    Kanis, S.
    de Lima, A.
    van der Woude, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S11 - S11
  • [7] OPTIMAL ANTI-TNF STOP WEEK DURING PREGNANCY DEPENDS ON ANTI-TNF TYPE
    Kanis, Shannon L.
    de Lima, Alison
    Van der Woude, Christien Janneke
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S85 - S85
  • [8] THE SAFETY OF ANTI-TNF AGENTS IN THE ELDERLY
    Migliore, A.
    Bizzi, E.
    Lagana, B.
    Altomonte, L.
    Zaccari, G.
    Granata, M.
    Canzoni, M.
    Marasini, B.
    Massarotti, M.
    Massafra, U.
    Ranieri, M.
    Pilla, R.
    Martin, L. S.
    Pezza, M.
    Vacca, F.
    Galluccio, A.
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (02) : 415 - 426
  • [9] Validation of the Pharmacokinetic Model for Anti-TNFα Clearance in Infants Exposed to Anti-TNFα During Pregnancy
    Wieringa, Jantien W.
    Kruizinga, Matthijs D.
    Driessen, Gertjan J. A.
    van der Woude, C. Janneke
    Julsgaard, Mette
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 (04): : 506 - 515
  • [10] Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease
    Gisbert, Javier P.
    Chaparro, Maria A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (09): : 1426 - 1438
12345